Viewing Study NCT02356159

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:51 PM
Ignite Modification Date: 2026-02-02 @ 6:20 PM
Study NCT ID: NCT02356159
Status: COMPLETED
Last Update Posted: 2025-09-30
First Post: 2015-02-04
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes View
None Hodgkin's Lymphoma View
None Non-Hodgkin's Lymphoma View
None Acute Leukemia View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hematopoietic Stem Cell Transplant View
None Lymphoma View
None Leukemia View
None Unrelated Donors View